Search is Powered by Google
Lymphoma / Leukemia News

Tough Journey For Families Of Children With Lymphoma

Main Category: Lymphoma / Leukemia
Also Included In: Cancer / Oncology;  Pediatrics / Children's Health;  Psychology / Psychiatry
Article Date: 29 Aug 2008 - 1:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article
Current Article Ratings:

Patient / Public:4 stars

4 (2 votes)

Health Professional:5 stars

5 (1 votes)

Article Opinions: 1 posts

A CQUniversity study has shown that families of children suffering from lymphoma face unique challenges that potentially make it more difficult to cope with the treatment experience than most.

According to the International Program of Psycho-Social Health Research (IPP-SHR) Senior Research Fellow Dr Pam McGrath, up until now there has been a shortage of information about the unique psycho-social experiences of these patients and their families.

IPP-SHR researchers extended a 5-year research study that has been exploring the treatment experiences of families coping with children with leukaemia to also include families with children diagnosed with lymphoma.

"This research found that lymphoma families perceived that treatment experiences as far more arduous than that of other childhood haematological groups, such as Acute Lymphatic Leukaemia (ALL)," Dr McGrath explained.

"Children diagnosed with ALL endure several years of treatment whilst the treatment protocol for the lymphoma population in comparatively short, lasting about 6 to 9 months. Due to the short treatment length, families are exposed to an intense treatment experience which rarely offers the opportunity for some respite from the difficult journey.

"The stress of treatment is further exacerbated when families have been relocated from rural areas to the metropolitan treatment centre. There is simply no time to return home to reconnect with family and to relax in the comfort and privacy of their own home."

The study also showed that the rarity of this disease caused parents to feel isolated from other families of children with cancer and were not provided with information and support services specific to their needs.

"In this largely unexplored area of paediatric oncology … these findings underscore the need for diagnostic specific support services for patients and their families," Dr McGrath said.

IPP-SHR is a collaborative initiative jointly funded by CQUniversity Australia and the National Health & Medical Research Council. It aims to document and examine the human experience of serious illness and 'make a difference' to those at the coalface of healthcare.

- Psycho-Social update Volume 3 Issue 2

- Link to request full published article

- Link to Project Page

CQUniversity




Customized Homepage Weekly Newsletters Daily News Alerts
Home About Us News Licensing Free Website Feeds Free Tools & Content Links Tell a Friend Accessibility Help / FAQ Article Submission Contact Us
Psychiatry Urology
Bipolar Diabetes Schizophrenia

add medical news today to your facebook

medical news gadget

Add to Google


developers
website gadget code
website news code
medical news rss feed links


MedReader RSS Reader

customize your homepage


These are the most read articles from this news category for the last 6 months:
Top Article Star
Case Of Patient "Cured" Of HIV Baffles Doctors
14 Nov 2008
Doctors and experts are baffled by the case of a 42-year old male American patient living in Berlin whose 10-year long HIV infection appears to have been "cured" by a bone marrow transplant given to treat his acute myeloid leukemia...


Monitoring and Adherence in CML image Monitoring and Adherence in CML

Imatinib, or Gleevec, is a targeted anti-cancer drug that can keep chronic myelogenous leukemia (CML) in check for most patients for many years. It is important for patients to take imatinib as prescribed by their doctor to fight the disease and to guard against resistance...

Treating Lymphoma Early image Treating Lymphoma Early

Non-Hodgkin's lymphoma is a cancer of the immune system. First-line treatment options include radiation therapy, chemotherapy, immunotherapy, radioimmunotherapy and stem cell transplant. How do you figure out which is right for you...

View more videos...